CPB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Campbell's Co (CPB) does not present a compelling buy opportunity for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock is facing significant headwinds, including weak financial performance, bearish technical indicators, and negative sentiment from analysts. While the dividend yield is high at 7.4%, it is at risk due to the company's financial struggles and prioritization of debt reduction. Without strong positive catalysts or a clear recovery path, it is advisable to hold off on investing in CPB at this time.
The technical indicators for CPB are bearish. The MACD histogram is negative and contracting, the RSI is neutral at 21.448, and the moving averages indicate a downward trend (SMA_200 > SMA_20 > SMA_5). Key support levels are at 20.721 and 20.349, while resistance levels are at 21.924 and 22.296. The stock is trading below its pivot point of 21.323, suggesting further downside risk.
Hedge funds are significantly increasing their positions in CPB, with a 10801.13% increase in buying activity over the last quarter. The stock's high dividend yield of 7.4% could attract income-focused investors.
Analysts have consistently lowered price targets and ratings for CPB, citing weak financial performance, elevated leverage, and risks to dividend sustainability. The company's Q2 financials showed a YoY decline in revenue (-4.51%), net income (-16.18%), and EPS (-17.24%). Gross margin also fell by 7.42%. Additionally, the stock has dropped 41% over the past year, reflecting poor investor sentiment.
In Q2 2026, Campbell's reported a revenue decline of 4.51% YoY to $2.564 billion. Net income dropped 16.18% YoY to $145 million, and EPS fell 17.24% to $0.48. Gross margin decreased to 27.93%, down 7.42% YoY. These figures indicate weakening profitability and operational challenges.
Analysts have a predominantly negative outlook on CPB. Multiple firms, including TD Cowen, UBS, and Wells Fargo, have lowered price targets to the $20-$26 range and downgraded ratings, citing weak Q2 results, underperformance in the Snacks segment, and concerns about dividend sustainability. The consensus reflects limited earnings visibility and ongoing financial struggles.
